127 related articles for article (PubMed ID: 26990844)
1. Assessment of Antishivering Medication Requirements During Therapeutic Normothermia: Effect of Cooling Methods.
Kirk A; McDaniel C; Szarlej D; Rincon F
Ther Hypothermia Temp Manag; 2016 Aug; 6(3):135-9. PubMed ID: 26990844
[TBL] [Abstract][Full Text] [Related]
2. Pre Versus Post Implementation of a Pharmacologic Antishivering Protocol During Targeted Temperature Management Following Cardiac Arrest.
Huynh C; Lui J; Behbahani V; Thompson Quan A; Morris A; Baumgartner L
Neurocrit Care; 2022 Apr; 36(2):511-518. PubMed ID: 34498206
[TBL] [Abstract][Full Text] [Related]
3. Minimizing Shivering During Targeted Normothermia: Comparison Between Novel Transnasal and Surface Temperature-Modulating Devices.
Arnold S; Armahizer M; Torres LF; Tripathi H; Tandri H; Chang JJ; Choi HA; Badjatia N
Neurocrit Care; 2023 Dec; 39(3):639-645. PubMed ID: 37498457
[TBL] [Abstract][Full Text] [Related]
4. Suppression of shivering during hypothermia using a novel drug combination in healthy volunteers.
Lenhardt R; Orhan-Sungur M; Komatsu R; Govinda R; Kasuya Y; Sessler DI; Wadhwa A
Anesthesiology; 2009 Jul; 111(1):110-5. PubMed ID: 19512867
[TBL] [Abstract][Full Text] [Related]
5. Shivering Treatments for Targeted Temperature Management: A Review.
Jain A; Gray M; Slisz S; Haymore J; Badjatia N; Kulstad E
J Neurosci Nurs; 2018 Apr; 50(2):63-67. PubMed ID: 29278601
[TBL] [Abstract][Full Text] [Related]
6. Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale.
Badjatia N; Strongilis E; Gordon E; Prescutti M; Fernandez L; Fernandez A; Buitrago M; Schmidt JM; Ostapkovich ND; Mayer SA
Stroke; 2008 Dec; 39(12):3242-7. PubMed ID: 18927450
[TBL] [Abstract][Full Text] [Related]
7. First Use of a New Device for Administration of Buspirone and Acetaminophen to Suppress Shivering During Therapeutic Hypothermia.
Honasoge A; Parker B; Wesselhoff K; Lyons N; Kulstad E
Ther Hypothermia Temp Manag; 2016 Mar; 6(1):48-51. PubMed ID: 26807775
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine Reduces Shivering during Mild Hypothermia in Waking Subjects.
Callaway CW; Elmer J; Guyette FX; Molyneaux BJ; Anderson KB; Empey PE; Gerstel SJ; Holquist K; Repine MJ; Rittenberger JC
PLoS One; 2015; 10(8):e0129709. PubMed ID: 26237219
[TBL] [Abstract][Full Text] [Related]
9. Magnesium sulfate increases the rate of hypothermia via surface cooling and improves comfort.
Zweifler RM; Voorhees ME; Mahmood MA; Parnell M
Stroke; 2004 Oct; 35(10):2331-4. PubMed ID: 15322301
[TBL] [Abstract][Full Text] [Related]
10. Safety and Feasibility of a Novel Transnasal Cooling Device to Induce Normothermia in Febrile Cerebrovascular Patients.
Badjatia N; Gupta N; Sanchez S; Haymore J; Tripathi H; Shah R; Hannan C; Tandri H
Neurocrit Care; 2021 Apr; 34(2):500-507. PubMed ID: 32666372
[TBL] [Abstract][Full Text] [Related]
11. Esophageal Cooling Device Versus Other Temperature Modulation Devices for Therapeutic Normothermia in Subarachnoid and Intracranial Hemorrhage.
Khan I; Haymore J; Barnaba B; Armahizer M; Melinosky C; Bautista MA; Blaber B; Chang WT; Parikh G; Motta M; Badjatia N
Ther Hypothermia Temp Manag; 2018 Mar; 8(1):53-58. PubMed ID: 29236581
[TBL] [Abstract][Full Text] [Related]
12. A trial of therapeutic hypothermia via endovascular approach in awake patients with acute ischemic stroke: methodology.
Guluma KZ; Hemmen TM; Olsen SE; Rapp KS; Lyden PD
Acad Emerg Med; 2006 Aug; 13(8):820-7. PubMed ID: 16766740
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine and meperidine additively reduce the shivering threshold in humans.
Doufas AG; Lin CM; Suleman MI; Liem EB; Lenhardt R; Morioka N; Akça O; Shah YM; Bjorksten AR; Sessler DI
Stroke; 2003 May; 34(5):1218-23. PubMed ID: 12690216
[TBL] [Abstract][Full Text] [Related]
14. Magnesium sulphate only slightly reduces the shivering threshold in humans.
Wadhwa A; Sengupta P; Durrani J; Akça O; Lenhardt R; Sessler DI; Doufas AG
Br J Anaesth; 2005 Jun; 94(6):756-62. PubMed ID: 15749735
[TBL] [Abstract][Full Text] [Related]
15. Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol.
Choi HA; Ko SB; Presciutti M; Fernandez L; Carpenter AM; Lesch C; Gilmore E; Malhotra R; Mayer SA; Lee K; Claassen J; Schmidt JM; Badjatia N
Neurocrit Care; 2011 Jun; 14(3):389-94. PubMed ID: 21210305
[TBL] [Abstract][Full Text] [Related]
16. A prospective, observational clinical trial of fever reduction to reduce systemic oxygen consumption in the setting of acute brain injury.
Hata JS; Shelsky CR; Hindman BJ; Smith TC; Simmons JS; Todd MM
Neurocrit Care; 2008; 9(1):37-44. PubMed ID: 17985248
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic temperature modulation for fever after intracerebral hemorrhage.
Lord AS; Karinja S; Lantigua H; Carpenter A; Schmidt JM; Claassen J; Agarwal S; Connolly ES; Mayer SA; Badjatia N
Neurocrit Care; 2014 Oct; 21(2):200-6. PubMed ID: 24420694
[TBL] [Abstract][Full Text] [Related]
18. Buspirone and meperidine synergistically reduce the shivering threshold.
Mokhtarani M; Mahgoub AN; Morioka N; Doufas AG; Dae M; Shaughnessy TE; Bjorksten AR; Sessler DI
Anesth Analg; 2001 Nov; 93(5):1233-9. PubMed ID: 11682404
[TBL] [Abstract][Full Text] [Related]
19. Implementing a Stepwise Shivering Protocol During Targeted Temperature Management.
Bock CA; Medford WG; Coughlin E; Mhaskar R; Sunjic KM
J Pharm Pract; 2023 Aug; ():8971900231193533. PubMed ID: 37551844
[No Abstract] [Full Text] [Related]
20. Determinants of effective cooling during endovascular hypothermia.
Lyden P; Ernstrom K; Cruz-Flores S; Gomes J; Grotta J; Mullin A; Rapp K; Raman R; Wijman C; Hemmen T
Neurocrit Care; 2012 Jun; 16(3):413-20. PubMed ID: 22466971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
